Stockreport

Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer

Veracyte, Inc.  (VCYT) 
Last veracyte, inc. earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF Findings from the first prospective validation trial for biomarker presented at ASTRO 2025 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) [Read more]